Xconomy Seattle

OncoGenex Pharmaceuticals Lands $9,500,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed5fe3e3-b4dc-4288-8316-fbe23941db26&Preview=1
Date
7/20/2009
Company Name
OncoGenex Pharmaceuticals
Mailing Address
1522 217th Place SE Bothell, WA 98021
Company Description
OncoGenex Pharmaceuticals is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address unmet needs in the treatment of cancer. We have a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development.
Website
http://www.oncogenex.com/
Transaction Type
Venture Equity
Transaction Amount
$9,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Undisclosed